May 06, 2021 09:17 PM IST

Moderna sees no impact on COVID-19 vaccine from potential patent waiver

The comments come a day after the United States said it would support waiving intellectual property rights for COVID-19 vaccines in order to help speed an end to the pandemic, paving the way for what could be months of negotiations to hammer out a specific waiver plan.

Joe Biden’s COVID-19 vaccine shift has risky side effects

Pfizer says it told India there is no safety concern with its COVID-19 vaccine

Pfizer, which produces the COVID-19 vaccine with German partner BioNTech, reiterated that it would supply doses only through government contracts.

Pfizer in talks with govt to expedite vaccine delivery, donates $70 million worth COVID-19 drugs to India

Last month, the pharmaceutical major had offered a not-for-profit price for its COVID-19 vaccine for the Indian government's immunisation programme.

Top US senators ask Pfizer, Moderna, J&J for global access to vaccines, including in India

"COVID-19 has infected over 148 million people and killed over three million globally, with hundreds of thousands of new cases and thousands of deaths being reported daily," the five senators wrote in identical letters to the CEOs of Pfizer, Moderna and Johnson & Johnson on Wednesday.

VAV Lifesciences to supply key COVID vaccine ingredient to Pfizer, Moderna

The city-based VAV Lifesciences is the only domestic firm in the COVID-19 vaccine supply chain with this crucial ingredient. It can thus can play a vital role in the global mRNA-based vaccine supply chain

Pfizer vaccine partially effective against Indian variant

An initial seven cases of the Indian variant were detected in Israel last week among people arriving from abroad and who have since undergo preliminary testing, the Health Ministry said.

COVID-19 vaccines | Moderna has its 'hands full', Pfizer wants signing of indemnity bond for supplying doses to India

While Moderna is 'not keen' to enter India because of its existing supply commitments, Pfizer's entry is conditional upon signing of an indemnity bond, a news report suggests.

COVID-19 update | European Union to get 50 million Pfizer doses early as Denmark scraps AstraZeneca

Elderly show similar antibody response to first dose of AstraZeneca, Pfizer COVID-19 shots: UK study

The UK study also found that a critical component of the immune system known as T cells showed a more enhanced response in those who got the AstraZeneca/Oxford University vaccine than in those who got the Pfizer/BioNTech one.

Pfizer asks United States to allow more kids to get vaccine

New York-based Pfizer and BioNTech SE of Germany have asked the US Food and Drug Administration to expand the emergency use authorisation for their vaccine to include adolescents ages 12 through 15.

Australia backs Pfizer virus vaccine over AstraZeneca for under-50s

The move, after Europe’s drug regulator found a possible link between the Anglo-Swedish vaccine and rare blood clotting issues, is a huge hurdle for Australia's faltering inoculation effort, which relies heavily on the AstraZeneca vaccine.

Researchers Are Hatching a Low-Cost Coronavirus Vaccine

If NDV-HXP-S proves safe and effective, flu vaccine manufacturers could potentially produce well over a billion doses of it a year. Low- and middle-income countries currently struggling to obtain vaccines from wealthier countries may be able to make NDV-HXP-S for themselves or acquire it at low cost from neighbors.

US markets expected to continue giving good returns to Indian investors: Sitashwa Srivastava of Stockal

After the onset of the lockdown, we at Stockal saw a 300% growth in Indian investors on the platform. In terms of volumes, Stockal processed $400 million worth of transactions during this financial year, says Srivastava.

Pfizer/BioNTech COVID-19 vaccine 91% effective in updated data, protective against South African variant

Pfizer's CEO Albert Bourla said the updated result positions the drugmakers to submit for full US regulatory approval for the vaccine against COVID-19.

Pfizer says its COVID-19 vaccine found 100% effective on children aged 12-15

The absolute efficacy of the vaccine was recorded in the third phase of clinical trials on the minor volunteers.

Pfizer, BioNTech launch COVID-19 vaccine trial in kids under 12

The Pfizer-BioNTech vaccine against COVID-19 was authorized by US regulators in late December for people age 16 and older.

Hong Kong and Macau suspend Pfizer/BioNTech vaccine over 'flawed' vials

The statements from Hong Kong and Macau did not give any details on how the packaging was defective.

Pfizer wants to make vaccine in India if faster clearance, export freedom assured: Report

The US company pulled an application last month seeking emergency approval for its product in India after the drug regulator declined its request to skip a small local safety trial. That has kept its vaccine, developed with Germany's BioNTech SE, out of one of the world's biggest drug markets.

Pfizer vaccine effective against Brazil, UK and South Africa COVID-19 strains: Study

Pfizer-BioNTech vaccine, however, showed a “robust but lower” activity against the South Africa variant.

UK's COVID-19 vaccine rollout expands to over-56 age groups

Letters from the National Health Service (NHS) to around 850,000 people in that age group were issued this weekend with a further 850,000 due to arrive by Monday.

With many vaccinated, Israel reopens economy before election

The easing of restrictions comes after months of government-imposed shutdowns and less than three weeks before the countrys fourth parliamentary elections in two years.

US scientists doubtful of one-shot regimen for Pfizer, Moderna COVID vaccines

"It is essential that these vaccines be used as authorized by FDA in order to prevent Covid-19 and related hospitalizations and death," Peter Marks, director of the FDA's Center for Biologics Evaluation and Research, told the Journal.

Pfizer requirements causing delays in COVAX deliveries: GAVI

Seth Berkley, CEO of the GAVI alliance that co-leads the COVAX multilateral vaccine facility with the World Health Organization (WHO), told journalists the requirements were partly related to indemnification issues.

Anthony Fauci says US must stick to two-shot strategy for Pfizer, Moderna COVID-19 vaccines

Fauci said that delaying a second dose to inoculate more Americans creates risks, the newspaper on Monday.